Levocarb

Levodopa/Carbidopa, the active ingredient in Levocarb, is an Antiparkinson agent presented as an oral tablet for systemic administration. It restores central dopamine levels to alleviate motor and non‑motor symptoms of Parkinson's disease and other Parkinsonian syndromes in adult patients through sustained therapy.

GNH USA supplies Levocarb as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide, serving both public and private healthcare institutions across Europe and other regions under strict quality standards and regulatory compliance.

Levocarb (Levodopa/Carbidopa) is employed in the management of Parkinsonian disorders, addressing dopaminergic deficiency.

- Parkinson's disease: improves motor function, reduces rigidity, bradykinesia, and tremor. - Parkinsonian syndrome: alleviates symptoms of secondary Parkinsonism such as gait disturbance and stiffness. - Levodopa‑responsive Parkinsonism: enhances daily activities by restoring central dopamine. - Motor fluctuations in advanced Parkinson's disease: smooths on‑off periods and prolongs “on” time. - Tremor‑dominant Parkinson's disease: reduces tremor amplitude and improves coordination.

Levocarb may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea - Vomiting - Dizziness or light‑headedness - Orthostatic hypotension

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Psychosis or hallucinations - Severe hypotension leading to syncope

When prescribing Levocarb, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor for dyskinesia: assess motor complications regularly. - Evaluate cardiovascular status: watch for orthostatic hypotension and arrhythmias. - Adjust dose in renal or hepatic impairment: start low and titrate cautiously. - Use with caution in patients with psychiatric history: risk of psychosis may increase. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocarb can interact with several medications, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective MAO inhibitors (e.g., phenelzine): may cause hypertensive crisis. - Antipsychotics (dopamine antagonists): reduce therapeutic effect and may worsen Parkinsonism. - Antihypertensive agents (e.g., alpha‑blockers): increase risk of severe hypotension.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: may enhance serotonergic activity, requiring monitoring. - Iron or calcium supplements: can impair levodopa absorption; separate dosing by at least 2 hours. - Vitamin B6 (pyridoxine): may increase peripheral conversion of levodopa, reducing efficacy.